FDA Panel Asks: Are Asthma Drugs Safe? The FDA's expert panels on asthma, drug safety, and pediatrics vote this week on safety questions about asthma drugs Serevent, Symbicort, and Foradil.

FDA Panel Asks: Are Asthma Drugs Safe?
The FDA’s expert panels on asthma, drug safety, and pediatrics vote this week on safety questions about asthma drugs Serevent, Symbicort, and Foradil.

Source link

What do you think?

12 Points
Upvote Downvote

Advair childrenAdvair riskAdvair safetyasksasthmaasthma drug death riskasthma drug riskasthma drug safetyasthma inhaler safetychild asthma drug safetychild asthma drugsDaniel DeNoondrugdrugsexpertfdaFDA panel asthmaFDA039sForadilForadil childrenForadil riskForadil safetyHealthHealth Newslong-acting beta agonist safetypanelPanelspediatricsquestionssafesafetySereventSerevent childrenSerevent riskSerevent safetySymbicortSymbicort childrenSymbicort riskSymbicort safetyVoteweek

Leave a Reply